Amgen's bispecific antibody puffs across finish line.
Cormac
C
Sheridan
D018033:Antibodies, Bispecific / Q000276:immunology*; D002986:Clinical Trials as Topic; D004345:Drug Industry; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology
D018033:Antibodies, Bispecific